Portage Biotech Inc. (PRTG)
NASDAQ: PRTG · Real-Time Price · USD
5.01
-0.57 (-10.22%)
Nov 4, 2024, 4:00 PM EST - Market closed
Portage Biotech Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Selling, General & Admin | 5.83 | 5.66 | 7.1 | 8.82 | 4.93 | 1.87 | Upgrade
|
| Research & Development | 10.21 | 12.54 | 8.67 | 6.77 | 7.31 | 4.11 | Upgrade
|
| Operating Expenses | 16.09 | 18.25 | 15.78 | 15.59 | 12.24 | 5.98 | Upgrade
|
| Operating Income | -16.09 | -18.25 | -15.78 | -15.59 | -12.24 | -5.98 | Upgrade
|
| Interest Expense | -0.03 | -0.03 | -0.01 | -0.04 | -0.18 | -0.56 | Upgrade
|
| Interest & Investment Income | 0.24 | 0.27 | 0.22 | - | - | 0.01 | Upgrade
|
| Earnings From Equity Investments | -0.18 | -0.23 | -0.26 | -0.06 | -0.49 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | 0.01 | -0.05 | 0.02 | - | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 4.08 | 2.94 | 0.03 | 0.85 | -0.79 | 0.02 | Upgrade
|
| EBT Excluding Unusual Items | -12 | -15.3 | -15.85 | -14.82 | -13.7 | -6.48 | Upgrade
|
| Merger & Restructuring Charges | - | - | -0.8 | - | -0.2 | - | Upgrade
|
| Impairment of Goodwill | - | - | -43.86 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.43 | -0.43 | -0.82 | - | 0.07 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.41 | - | Upgrade
|
| Other Unusual Items | 12.42 | 11.31 | 2.71 | - | -1.48 | -0.03 | Upgrade
|
| Pretax Income | -81.52 | -85.93 | -122.52 | -14.82 | -14.89 | -6.51 | Upgrade
|
| Income Tax Expense | -10.4 | -10.55 | -17.86 | 4.35 | 2.3 | 0.74 | Upgrade
|
| Earnings From Continuing Operations | -71.12 | -75.38 | -104.67 | -19.17 | -17.19 | -7.25 | Upgrade
|
| Minority Interest in Earnings | 0.04 | 0.04 | 0.06 | 2.3 | 1.36 | 1.92 | Upgrade
|
| Net Income | -71.08 | -75.34 | -104.61 | -16.87 | -15.83 | -5.33 | Upgrade
|
| Net Income to Common | -71.08 | -75.34 | -104.61 | -16.87 | -15.83 | -5.33 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 17.18% | 20.00% | 23.42% | 11.31% | 7.13% | 127.22% | Upgrade
|
| EPS (Basic) | -70.50 | -77.90 | -129.80 | -25.83 | -26.99 | -9.74 | Upgrade
|
| EPS (Diluted) | -70.50 | -77.90 | -129.80 | -25.83 | -27.00 | -9.80 | Upgrade
|
| Free Cash Flow | -12.53 | -14.3 | -12.08 | -6.76 | -4.28 | -3.71 | Upgrade
|
| Free Cash Flow Per Share | -12.43 | -14.78 | -14.98 | -10.36 | -7.30 | -6.78 | Upgrade
|
| EBITDA | -16.04 | -18.2 | -15.78 | - | - | - | Upgrade
|
| D&A For EBITDA | 0.05 | 0.05 | 0 | - | - | - | Upgrade
|
| EBIT | -16.09 | -18.25 | -15.78 | -15.59 | -12.24 | -5.98 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.